Didn’t get a chance to watch all of the broadcasts in May or just want to re-cap on the session?
Why not view the on-demand videos and resources designed to address the primary care challenges of diagnosing and managing chronic conditions at a time when COVID-19 has thrown out the rule book.
Clinical Lead in Dementia and Mental Health, South Glos CCG, and Director of the South West Clinical Network for Dementia
GPwSI in Diabetes and Medical Education, North Berwick Group Practice
Portfolio GP with Extended roles in Drug & Alcohol treatment and musculoskeletal pain, Leicester
Clinical Respiratory Lead, NHS Somserset
Cardiovascular and Diabetes Clinical Lead, Nene CCG
Use of steroids: what to be aware of and how to manage it in primary care
Palpitations – when to worry and what is the interplay with mental illness?
Severe mental illness and diabetes
Living with cancer and the inter-relationship with long-term conditions
Importance of testing chronic kidney disease
Opioids and musculoskeletal pain
BOEHRINGER INGELHEIM IN THE UK: We are Boehringer Ingelheim – a different kind of pharmaceutical company. Family-owned. Purpose-led. Innovation-driven: We serve mankind by aiming to improve health for people and animals.
Established in 1885, we have always been independent and family-owned, meaning we have the freedom to pursue our purpose – identifying health challenges of the future, and targeting areas of need where we can do the most good.
By working collaboratively, we aim to accelerate the delivery of medical breakthroughs to improve the lives of patients now, and for generations to come.
In the UK we do this through scientific innovation – taking on the biggest challenges in medicine. We invest in sustainable healthcare – planning for the long term alongside the NHS and our partners in the veterinary world. We support digital transformation by partnering with innovators to drive healthcare improvements.
This webcast series and supporting materials was developed by the Chronic Conditions faculty in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the agenda, speaker selection, presentations or collateral content, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.